Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 297, Issue 6, 2009, Pages

  Kake, Takei ^a   Kitamura, Hidetomo ^a,d   Adachi, Yuichiro ^a,e   Yoshioka, Tetsuro ^b   Watanabe, Tomoyuki ^a   Matsushita, Hiroaki ^a   Fujii, Toshihito ^b   Kondo, Eri ^b   Tachibe, Takanori ^c   Kawase, Yosuke ^c   Jishage, Kou Ichi ^c   Yasoda, Akihiro ^b   Mukoyama, Masashi ^b   Nakao, Kazuwa ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Chugai Research Institute for Medical Science Inc   (Japan)

^d Portfolio Management Unit   (Japan)

^e NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Blood level elevation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; GUANYLATE CYCLASE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE TYPE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE VARIABILITY; BONE GROWTH; CARTILAGE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; FEMALE; FORAMEN MAGNUM; GENE OVEREXPRESSION; GROWTH REGULATION; HEART WEIGHT; HYPOTENSION; LIMB; MALE; MOUSE; NATRIURETIC PEPTIDE TYPE C BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RIB; SKULL; SPINE; SYSTOLIC BLOOD PRESSURE; TRANSGENIC MOUSE;

ABSORPTIOMETRY, PHOTON; ANIMALS; BLOOD PRESSURE; BONE DENSITY; BONE DEVELOPMENT; FEMALE; GUANYLATE CYCLASE; HEART; HINDLIMB; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NATRIURETIC PEPTIDE, C-TYPE; ORGAN SIZE; OSTEOGENESIS; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 72249085559     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00272.2009     Document Type: Article

References (36)

1. Aviezer D, Golembo M, Yayon A. Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia - genetic short limbed dwarfism. Curr Drug Targets 4: 353-365, 2003. (Pubitemid 36763493)
2. Bartels CF, Bükülmez H, Padayatti P, Rhee DK, van Ravenswaaij-Arts C, Pauli RM, Mundlos S, Chitayat D, Shih LY, Al-Gazali LI, Kant S, Cole T, Morton J, Cormier-Daire V, Faivre L, Lees M, Kirk J, Mortier GR, Leroy J, Zabel B, Kim CA, Crow Y, Braverman NE, van den Akker F, Warman ML. Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 75: 27-34, 2004. (Pubitemid 38801898)
3. Bocciardi R, Giorda R, Buttgereit J, Gimelli S, Divizia MT, Beri S, Garofalo S, Tavella S, Lerone M, Zuffardi O, Bader M, Ravazzolo R, Gimelli G. Overexpression of the C-type natriuretic peptide (CNP) is associated with overgrowth and bone anomalies in an individual with balanced t(2;7) translocation. Hum Mutat 28: 724-731, 2007. (Pubitemid 47049611)
4. Brandt RR, Heublein DM, Aarhus LL, Lewicki JA, Burnett JC Jr. Role of natriuretic peptide clearance receptor in in vivo control of C-type natriuretic peptide. Am J Physiol Heart Circ Physiol 269: H326-H331, 1995.
5. Chusho H, Tamura N, Ogawa Y, Yasoda A, Suda M, Miyazawa T, Nakamura K, Nakao K, Kurihara T, Komatsu Y, Itoh H, Tanaka K, Saito Y, Katsuki M, Nakao K. Dwarfism and early death in mice lacking C-type natriuretic peptide. Proc Natl Acad Sci USA 98: 4016-4021, 2001. (Pubitemid 32249890)
6. Ho NC, Guarnieri M, Brant LJ, Park SS, Sun B, North M, Francomano CA, Carson BS. Living with achondroplasia: quality of life evaluation following cervico-medullary decompression. Am J Med Genet A 131: 163-167, 2004. (Pubitemid 39578348)
7. Honing ML, Smits P, Morrison PJ, Burnett JC Jr, Rabelink TJ. C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels. Hypertension 37: 1179-1183, 2001. (Pubitemid 32304022)
8. Horton WA. Skeletal development: insights from targeting the mouse genome. Lancet 362: 560-569, 2003.
9. Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab 78: 1428-1435, 1994.
10. Kronenberg HM. Developmental regulation of the growth plate. Nature 423: 332-336, 2003.
11. Lopez MJ, Garbers DL, Kuhn M. The guanylyl cyclase-deficient mouse defines differential pathways of natriuretic peptide signaling. J Biol Chem 272: 23064-23068, 1997. (Pubitemid 27392432)
12. Lu B, Gerard NP, Kolakowski LF Jr, Bozza M, Zurakowski D, Finco O, Carroll MC, Gerard C. Neutral endopeptidase modulation of septic shock. J Exp Med 181: 2271-2275, 1995.
13. Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, Smithies O. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci USA 96: 7403-7408, 1999. (Pubitemid 29299674)
14. Mehta A, Hindmarsh PC. The use of somatropin (recombinant growth hormone) in children of short stature. Paediatr Drugs 4: 37-47, 2002. (Pubitemid 34208345)
15. Miyazawa T, Ogawa Y, Chusho H, Yasoda A, Tamura N, Komatsu Y, Pfeifer A, Hofmann F, Nakao K. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification. Endocrinology 143: 3604-3610, 2002. (Pubitemid 34925737)
16. Mericq V, Uyeda JA, Barnes KM, De Luca F, Baron J. Regulation of fetal rat bone growth by C-type natriuretic peptide and cGMP. Pediatr Res 47: 189-193, 2000. (Pubitemid 30075627)
17. Nakao K, Itoh H, Saito Y, Mukoyama M, Ogawa Y. The natriuretic peptide family. Curr Opin Nephrol Hypertens 5: 4-11, 1996.
18. Newman B, Wallis GA. Skeletal dysplasias caused by a disruption of skeletal patterning and endochondral ossification. Clin Genet 63: 241-251, 2003. (Pubitemid 36949931)
19. Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, Nakao K. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest 93: 1911-1921, 1994.
20. Palmiter RD, Norstedt G, Gelinas RE, Hammer RE, Brinster RL. Metallothionein-human GH fusion genes stimulate growth of mice. Science 222: 809-814, 1983. (Pubitemid 14227548)
21. Pfeifer A, Aszódi A, Seidler U, Ruth P, Hofmann F, Fässler R. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II. Science 274: 2082-2086, 1996. (Pubitemid 27020701)
22. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27: 47-72, 2006. (Pubitemid 43228238)
23. Sengenés C, Berlan M, De Glisezinski I, Lafontan M, Galitzky J. Natriuretic peptides: a new lipolytic pathway in human adipocytes. FASEB J 14: 1345-1351, 2000. (Pubitemid 30439743)
24. Silberbach M, Roberts CT Jr. Natriuretic peptide signaling: molecular and cellular pathways to growth regulation. Cell Signal 13: 221-231, 2001. (Pubitemid 32295941)
25. Steinhelper ME, Cochrane KL, Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16: 301-307, 1990.
26. Suda M, Ogawa Y, Tanaka K, Tamura N, Yasoda A, Takigawa T, Uehira M, Nishimoto H, Itoh H, Saito Y, Shiota K, Nakao K. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide. Proc Natl Acad Sci USA 95: 2337-2342, 1998. (Pubitemid 28145942)
27. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system". J Clin Invest 90: 1145-1149, 1992.
28. Suga S, Nakao K, Hosoda K, Mukoyama M, Ogawa Y, Shirakami G, Arai H, Saito Y, Kambayashi Y, Inouye K, Imura H. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130: 229-239, 1992.
29. Tamura N, Doolittle LK, Hammer RE, Shelton JM, Richardson JA, Garbers DL. Critical roles of the guanylyl cyclase B receptor in endochondral ossification and development of female reproductive organs. Proc Natl Acad Sci USA 101: 17300-17305, 2004. (Pubitemid 39627814)
30. Tremblay J, Desjardins R, Hum D, Gutkowska J, Hamet P. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem 230: 31-47, 2002. (Pubitemid 34257240)
31. Turner AJ, Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 11: 355-364, 1997. (Pubitemid 27193940)
32. Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 21: 23-39, 2000. (Pubitemid 32260394)
33. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, Kurihara T, Rogi T, Tanaka S, Suda M, Tamura N, Ogawa Y, Nakao K. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10: 80-86, 2004. (Pubitemid 38524702)
34. Young JW, Kovelman H, Resnik CS, Paley D. Radiologic assessment of bones after Ilizarov procedures. Radiology 177: 89-93, 1990. (Pubitemid 20317327)
35. Zelzer E, Olsen BR. The genetic basis for skeletal diseases. Nature 423: 343-348, 2003.
36. Zhao X, Araki K, Miyazaki J, Yamamura K. Developmental and liver-specific expression directed by the serum amyloid P component promoter in transgenic mice. J Biochem 111: 736-738, 1992.